28.09.2009 Boehringer Ingelheim`s diabetes pipeline continues to advance as the Company announces conclusion of robust Phase III pivotal trials programme for linagliptin For medical media, outside the US only 22.09.2009 Boehringer Ingelheim Animal Health enters into agreement to acquire certain assets of Fort Dodge Animal Health from Pfizer For medical media, outside the US only 15.09.2009 Early administration of Aggrenox^® is effective and safe after acute ischaemic stroke or TIA For medical media, outside the US only 15.09.2009 New analysis supports tiotropium as initial maintenance therapy for COPD For medical media, outside the US only 14.09.2009 ERS COPD Research Award 2009 sponsored by Boehringer Ingelheim 11.09.2009 New data show patients with chronic low back pain maintained pain reduction on duloxetine 30.08.2009 Groundbreaking results in the RE-LY^® trial - novel oral direct thrombin inhibitor dabigatran etexilate convincingly beats warfarin - superior stroke reduction with less bleeding! 28.08.2009 Data from largest GOLD Stage II patient population treated with tiotropium highlight the benefits of earlier treatment of COPD For medical media, outside the US only 03.08.2009 Boehringer Ingelheim to commence Phase III study investigating the role of BIBW 2992 (Tovok^TM) as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR mutations 28.07.2009 Good first six months in 2009 for Boehringer Ingelheim - Successful products Spiriva^®, Micardis^® and Flomax^® secure good growth